Structural insight into the antagonistic action of diarylheptanoid on human estrogen receptor alpha

References

• Awasthi, M., Singh, S., Pandey, V. P., & Dwivedi, U. N. (2015). Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer. Journal of Biomolecular Structure and Dynamics, 33(4), 804–819. doi:10.1080/07391102.2014.912152
   PubMed Web of Science ®Google Scholar
• Balcao, V. M., & Vila, M. M. (2015). Structural and functional stabilization of protein entities: State-of-the-art. Advanced Drug Delivery Reviews, 93, 25–41. doi:10.1016/j.addr.2014.10.005
   PubMed Web of Science ®Google Scholar
• Basri, A. M., Taha, H., & Ahmad, N. (2017). A review on the pharmacological activities and phytochemicals of Alpinia officinarum (Galangal) extracts derived from bioassay-guided fractionation and isolation. Pharmacognosy Reviews, 11(21), 43. doi:10.4103/phrev.phrev_55_16
   PubMedGoogle Scholar
• Berendsen, H. J., Postma, J. P., van Gunsteren, W. F., & Hermans, J. (1981). Interaction models for water in relation to protein hydration. In Intermolecular forces (pp. 331–342). Springer Netherlands. doi:10.1007/978-94-015-7658-1_2110.1007/978-94-015-7658-1
   Google Scholar
• Berendsen, H. J., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1–3), 43–56. doi:10.1016/0010-4655(95)00042-E
   Web of Science ®Google Scholar
• Burks, H. E., Abrams, T., Kirby, C. A., Baird, J., Fekete, A., Hamann, L. G., & Macchi, K. (2017). Discovery of an acrylic acid based tetrahydroisoquinoline as an orally bioavailable selective estrogen receptor degrader for ERα+ breast cancer. Journal of Medicinal Chemistry, 60(7), 2790–2818. doi:10.1016/0010-4655(95)00042-E
   PubMed Web of Science ®Google Scholar
• Cao, H., Wang, F., Liang, Y., Wang, H., Zhang, A., & Song, M. (2017). Experimental and computational insights on the recognition mechanism between the estrogen receptor α with bisphenol compounds. Archives of Toxicology, 1–16. doi:10.1007/s00204-017-2011-0
   Web of Science ®Google Scholar
• Chakraborty, S., & Biswas, P. K. (2014). Structural insights into selective agonist actions of tamoxifen on human estrogen receptor alpha. Journal of Molecular Modeling, 20(8), 2338. doi:10.1007/s00894-014-2338-x
   PubMed Web of Science ®Google Scholar
• Chakraborty, S., Levenson, A. S., & Biswas, P. K. (2013). Structural insights into Resveratrol’s antagonist and partial agonist actions on estrogen receptor alpha. BMC Structural Biology, 13(1), 27. doi:10.1186/1472-6807-13-27
   PubMed Web of Science ®Google Scholar
• Chen, P., Wang, H., Yang, F., Chen, H., He, W., & Wang, J. (2017). Curcumin promotes osteosarcoma cell death by activating miR-125a/ERRα signal pathway. Journal of Cellular Biochemistry, 118(1), 74–81. doi:10.1002/jcb.25612
   PubMed Web of Science ®Google Scholar
• Dhananjaya, K., Sibi, G., Mallesha, H., Ravikumar, K. R., & Awasthi, S. (2012). Insilico studies of daidzein and genistein with human estrogen receptor α. Asian Pacific Journal of Tropical Biomedicine, 2(3), S1747–S1753. doi:10.1016/S2221-1691(12)60489-4
   Google Scholar
• Doan, T. B., Graham, J. D., & Clarke, C. L. (2017). Emerging functional roles of nuclear receptors in breast cancer. Journal of Molecular Endocrinology, 58(3), R169–R190. doi:10.1530/JME-16-0082
   PubMed Web of Science ®Google Scholar
• Ekena, K., Weis, K. E., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1997). Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens. Journal of Biological Chemistry, 272(8), 5069–5075. doi:10.1074/jbc.272.8.5069
   PubMed Web of Science ®Google Scholar
• Feng, W., Ribeiro, R. C., Wagner, R. L., Nguyen, H., Apriletti, J. W., Fletterick, R. J., & West, B. L. (1998). Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science, 280(5370), 1747–1749. doi:10.1126/science.280.5370.1747
   PubMed Web of Science ®Google Scholar
• Gao, L., Tu, Y., Agren, H., & Eriksson, L. A. (2012). Characterization of agonist binding to His524 in the estrogen receptor α ligand binding domain. The Journal of Physical Chemistry B, 116(16), 4823–4830. doi:10.1021/jp300895g
   PubMed Web of Science ®Google Scholar
• Ginsburg, O., Bray, F., Coleman, M. P., Vanderpuye, V., Eniu, A., Kotha, S. R., & Gralow, J. (2017). The global burden of women’s cancers: A grand challenge in global health. The Lancet, 389(10071), 847–860. doi:10.1016/S0140-6736(16)31392-7
   PubMed Web of Science ®Google Scholar
• Hall, J. M., & McDonnell, D. P. (2005). Coregulators in nuclear estrogen receptor action. Molecular Interventions, 5(6), 343. doi:10.1124/mi.5.6.7
   PubMedGoogle Scholar
• Hallman, K., Aleck, K., Dwyer, B., Lloyd, V., Quigley, M., Sitto, N., & Dinda, S. (2017). The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells. Breast Cancer: Targets and Therapy, 9, 153. doi:10.2147/BCTT.S125783
   PubMed Web of Science ®Google Scholar
• Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., & Gustafsson, J. A. (2007). Estrogen receptors: How do they signal and what are their targets. Physiological Reviews, 87(3), 905–931. doi:10.1152/physrev.00026.2006
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J., & Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. doi:10.1002/(ISSN)1096-987X10.1002/(ISSN)1096-987X
   Web of Science ®Google Scholar
• Hewitt, S. C., Winuthayanon, W., & Korach, K. S. (2016). What’s new in estrogen receptor action in the female reproductive tract. Journal of Molecular Endocrinology, 56(2), R55–R71. doi:10.1530/JME-15-0254
   PubMed Web of Science ®Google Scholar
• Hung, T. C., Lee, W. Y., Chen, K. B., Chan, Y. C., & Chen, C. Y. C. (2014). Investigation of estrogen receptor (ESR1) for breast cancer from traditional Chinese medicine. BioMed research international, 2014, doi:10.1155/2014/321486
   Google Scholar
• Jalili, S., & Saeedi, M. (2016). Study of curcumin behavior in two different lipid bilayer models of liposomal curcumin using molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 34(2), 327–340. doi:10.1080/07391102.2015.1030692
   PubMed Web of Science ®Google Scholar
• Jiang, M., Huang, O., Zhang, X., Xie, Z., Shen, A., Liu, H., & Shen, K. (2013). Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9. Molecules, 18(1), 701–720. doi:10.3390/molecules18010701
   PubMed Web of Science ®Google Scholar
• Kallubai, M., Reddy, S. P., Dubey, S., Ramachary, D. B., & Subramanyam, R. (2018). Spectroscopic evaluation of synthesized 5β-dihydrocortisol and 5β-dihydrocortisol acetate binding mechanism with human serum albumin and their role in anticancer activity. Journal of Biomolecular Structure and Dynamics, (just-accepted), 1–46. doi:10.1080/07391102.2018.143355410.1080/07391102.2018.1433554
   PubMed Web of Science ®Google Scholar
• Lee, S., & Barron, M. G. (2017). Structure-based understanding of binding affinity and mode of estrogen receptor α agonists and antagonists. PLOS ONE, 12(1), e0169607. doi:10.1371/journal.pone.0169607
   PubMed Web of Science ®Google Scholar
• Li, W. M., Li, X. B., Sun, S. X., Liang, J., Wang, R. L., & Wang, S. Q. (2013). Agonist and antagonist recognition studies for oestrogen receptor by molecular dynamics simulation. Molecular Simulation, 39(3), 228–233. doi:10.1080/08927022.2012.717281
   Web of Science ®Google Scholar
• Lovell, S. C., Davis, I. W., Arendall, W. B., de Bakker, P. I., Word, J. M., Prisant, M. G., & Richardson, D. C. (2003). Structure validation by Cα geometry: Φ, ψ and Cβ deviation. Proteins: Structure, Function, and Bioinformatics, 50(3), 437–450. doi:10.1002/prot.10286
   PubMed Web of Science ®Google Scholar
• Min, J., Guillen, V. S., Sharma, A., Zhao, Y., Ziegler, Y., Gong, P., … Nettles, K. W. (2017). Adamantyl antiestrogens with novel side chains reveal a spectrum of activities in suppressing estrogen receptor mediated activities in breast cancer cells. Journal of Medicinal Chemistry, 60(14), 6321–6336. doi:10.1021/acs.jmedchem.7b00585
   PubMed Web of Science ®Google Scholar
• Mota, K. B., Neto, J. L., Costa, A. L., Oliveira, J. I. N., Bezerra, K. S., Albuquerque, E. L., … Fulco, U. L. (2016). A quantum biochemistry model of the interaction between the estrogen receptor and the two antagonists used in breast cancer treatment. Computational and Theoretical Chemistry, 1089, 21–27. doi:10.1016/j.comptc.2016.05.006
   Web of Science ®Google Scholar
• Muchtaridi, M., Yusuf, M., Diantini, A., Choi, S. B., Al-Najjar, B. O., Manurung, J. V., & Wahab, H. A. (2014). Potential activity of Fevicordin-A from Phaleria macrocarpa (scheff) boerl. Seeds as estrogen receptor antagonist based on cytotoxicity and molecular modelling studies. International Journal of Molecular Sciences, 15(5), 7225–7249. doi:10.3390/ijms15057225
   PubMed Web of Science ®Google Scholar
• Oza, A., & Ma, C. X. (2017). New insights in estrogen receptor (ER) biology and implications for treatment. Current Breast Cancer Reports, 9(1), 13–25. doi:10.1007/s12609-017-0231-1
   Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF chimera – A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. doi:10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• SchuÈttelkopf, A. W., & van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallographica Section D: Biological Crystallography, 60(8), 1355–1363. doi:10.1107/S0907444904011679
   PubMedGoogle Scholar
• Scott, W. R., Hünenberger, P. H., Tironi, I. G., Mark, A. E., Billeter, S. R., Fennen, J., & van Gunsteren, W. F. (1999). The GROMOS biomolecular simulation program package. The Journal of Physical Chemistry A, 103(19), 3596–3607. doi:10.1021/jp984217f
   Web of Science ®Google Scholar
• Shao, Z. M., Shen, Z. Z., Liu, C. H., Sartippour, M. R., Go, V. L., Heber, D., & Nguyen, M. (2002). Curcumin exerts multiple suppressive effects on human breast carcinoma cells. International Journal of Cancer, 98(2), 234–240. doi:10.1002/ijc.10183
   PubMed Web of Science ®Google Scholar
• Singh, S., Awasthi, M., Pandey, V. P., & Dwivedi, U. N. (2017). Plant derived anti-cancerous secondary metabolites as multipronged inhibitor of COX, Topo, and aromatase: Molecular modeling and dynamics simulation analyses. Journal of Biomolecular Structure and Dynamics, 35(14), 3082–3097. doi:10.1080/07391102.2016.1241720
   PubMed Web of Science ®Google Scholar
• Skafar, D. F., & Koide, S. (2006). Understanding the human estrogen receptor-alpha using targeted mutagenesis. Molecular and Cellular Endocrinology, 246(1), 83–90. doi:10.1016/j.mce.2005.12.015
   PubMed Web of Science ®Google Scholar
• Srinivasan, S., Nwachukwu, J. C., Bruno, N. E., Dharmarajan, V., Goswami, D., Kastrati, I., & Boonmuen, N. (2017). Full antagonism of the estrogen receptor without a prototypical ligand side chain. Nature Chemical Biology, 13(1), 111–118. doi:10.1038/nchembio.2236
   PubMed Web of Science ®Google Scholar
• Subramanian, K., Selvakkumar, C., Vinaykumar, K. S., Goswami, N., Meenakshisundaram, S., Balakrishnan, A., & Lakshmi, B. S. (2009). Tackling multiple antibiotic resistance in enteropathogenic Escherichia coli (EPEC) clinical isolates: A diarylheptanoid from Alpinia officinarum shows promising antibacterial and immunomodulatory activity against EPEC and its lipopolysaccharide-induced inflammation. International Journal of Antimicrobial Agents, 33(3), 244–250. doi:10.1016/j.ijantimicag.2008.08.032
   PubMed Web of Science ®Google Scholar
• Thirumal Kumar, D., & George Priya Doss, C. (2017). Role of E542 and E545 missense mutations of PIK3CA in breast cancer: A comparative computational approach. Journal of Biomolecular Structure and Dynamics, 35(12), 2745–2757. doi:10.1080/07391102.2016.1231082
   PubMed Web of Science ®Google Scholar
• Thongon, N., Boonmuen, N., Suksen, K., Wichit, P., Chairoungdua, A., Tuchinda, P., & Piyachaturawat, P. (2017). Selective estrogen receptor modulator (SERM)-like activities of diarylheptanoid, a phytoestrogen from Curcuma comosa, in breast cancer cells, pre-osteoblast cells, and rat uterine tissues. Journal of Agricultural and Food Chemistry, 65(17), 3490–3496. doi:10.1021/acs.jafc.7b00769
   PubMed Web of Science ®Google Scholar
• Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995). LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Engineering, Design and Selection, 8(2), 127–134. doi:10.1093/protein/8.2.127
   Web of Science ®Google Scholar
• Wang, P., Dang, L., & Zhu, B. T. (2016). Use of computational modeling approaches in studying the binding interactions of compounds with human estrogen receptors. Steroids, 105, 26–41. doi:10.1016/j.steroids.2015.11.001
   PubMed Web of Science ®Google Scholar
• Williams, D. H., Stephens, E., O’Brien, D. P., & Zhou, M. (2004). Understanding noncovalent interactions: Ligand binding energy and catalytic efficiency from ligand-induced reductions in motion within receptors and enzymes. Angewandte Chemie International Edition, 43(48), 6596–6616. doi:10.1002/anie.200300644
   PubMed Web of Science ®Google Scholar
• Zafar, A., Ahmad, S., & Naseem, I. (2015). Insight into structural stability of coumestrol with human estrogen receptor α and estrogen receptor β subtypes: A combined approach in involving docking and molecular dynamic simulation studies. RCS Advances, 5, 81295–81312. doi:10.1039/C5RA14745J
   Google Scholar
• Zhou, D., Chen, G., Wang, J., & Li, N. (2017). Natural cancer chemopreventive reagents from food and herbals. Current Pharmacology Reports, 1–12. doi:10.1007/s40495-017-0089-y
   PubMedGoogle Scholar